## Core Concept
The biochemical abnormalities in schizophrenia involve various neurotransmitter systems, with a primary focus on dopamine and glutamate. The dopamine hypothesis of schizophrenia suggests that overactive dopaminergic pathways contribute to the positive symptoms of schizophrenia. Additionally, abnormalities in glutamatergic neurotransmission, particularly through N-methyl-D-aspartate (NMDA) receptors, are also implicated.

## Why the Correct Answer is Right
The correct answer, **D. Glutamate and dopamine imbalance**, is right because it accurately reflects the current understanding of the biochemical abnormalities in schizophrenia. Research has shown that schizophrenia is associated with an imbalance in glutamate and dopamine neurotransmission. The dopamine hypothesis explains many of the positive symptoms of schizophrenia, such as hallucinations and delusions. Meanwhile, the glutamatergic hypothesis, involving NMDA receptor dysfunction, is thought to contribute to the negative symptoms and cognitive impairments seen in schizophrenia.

## Why Each Wrong Option is Incorrect
- **Option A: Serotonin and GABA imbalance** - While serotonin and GABA are involved in the pathophysiology of schizophrenia, they are not the primary neurotransmitter systems implicated. Serotonin, for example, is more commonly associated with mood disorders.
- **Option B: Acetylcholine and norepinephrine imbalance** - These neurotransmitters play roles in various psychiatric and neurological conditions but are not primarily implicated in the core biochemical abnormalities of schizophrenia.
- **Option C: Only dopamine imbalance** - This option is too narrow, as it does not account for the significant evidence implicating glutamatergic dysfunction in schizophrenia. While dopamine imbalance is crucial, it is not the sole biochemical abnormality.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that the **atypical antipsychotics**, which are first-line treatments for schizophrenia, often have a broader mechanism of action that includes antagonism at dopamine D2 and D3 receptors, serotonin 5-HT2A receptors, and sometimes effects on glutamatergic neurotransmission. This complex pharmacology helps in managing both positive and negative symptoms of schizophrenia.

## Correct Answer: D. Glutamate and dopamine imbalance